FY2025 · period end Sep '25 · from the 10-K filed Nov 25, 2025
| Metric | FY25Sep '25 | FY24Sep '24 | FY23Sep '23 | FY22Sep '22 | FY21Sep '21 |
|---|---|---|---|---|---|
| Revenue | $3.09B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001048695-26-000059 | Jun 17, 2026 | Jun 23, 2026 | Jun 23, 2026 20:00 UTC | EDGAR |
| 10-Q | 0001048695-26-000051 | Mar 31, 2026 | May 5, 2026 | May 5, 2026 18:01 UTC | EDGAR |
| 8-K | 0001048695-26-000042 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 20:13 UTC | EDGAR |
| 8-K | 0001048695-26-000044 | Apr 24, 2026 | Apr 28, 2026 | Apr 28, 2026 20:14 UTC | EDGAR |
| 8-K | 0001048695-26-000036 | Mar 12, 2026 | Mar 13, 2026 | Mar 13, 2026 20:10 UTC | EDGAR |
| 10-Q | 0001048695-26-000023 | Dec 31, 2025 | Feb 5, 2026 | Feb 5, 2026 20:07 UTC | EDGAR |
| 8-K | 0001048695-26-000018 | Jan 27, 2026 | Jan 27, 2026 | Jan 27, 2026 21:12 UTC | EDGAR |
| 10-K | 0001048695-25-000157 | Sep 30, 2025 | Nov 25, 2025 | Nov 25, 2025 18:00 UTC | EDGAR |
Direct links to SEC EDGAR. FFIV has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Assets, Current·As of Sep 30, 2017
Notable restatementwas$1.5B
Revised down in a 10-K.
Share-based Payment Arrangement, Expense, Tax Benefit·FY 2019
Major restatementwas$4.5M
Revised up in a 10-K.
Share-based Payment Arrangement, Expense, Tax Benefit·FY 2018
Major restatementwas$9.4M
Revised up in a 10-K.
Deferred Tax Liabilities, Net, Noncurrent·As of Sep 30, 2017
Major restatementwas$4.3M
Revised down in a 10-K.
Deferred Income Tax Expense (Benefit)·FY 2010
Major restatementwas-$8.2M
Revised up in a 10-K.
Other Accrued Liabilities, Current·As of Sep 30, 2014
Major restatementwas$13.9M
Revised down in a 10-K.
FFIV is not the only one.
See every restatement we've found across the market — or get an alert the next time FFIV revises a number.
Restatements are detected by comparing every vintage of a fact across all of F5, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows FFIV's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling F5, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on FFIV yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on FFIV and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $2.81B |
| $2.70B |
| $2.60B |
| Gross Profit | $2.51B | $2.26B | $2.22B | $2.16B | $2.11B |
|---|
| Operating Income | $0.77B | $0.66B | $0.47B | $0.40B | $0.39B |
|---|
| Net Income | $0.69B | $0.57B | $0.39B | $0.32B | $0.33B |
|---|
| EPS (Diluted) | $11.80 | $9.55 | $6.55 | $5.27 | $5.34 |
|---|
| Metric | FY25Sep '25 | FY24Sep '24 | FY23Sep '23 | FY22Sep '22 | FY21Sep '21 |
|---|---|---|---|---|---|
| Total Assets | $6.32B | $5.61B | $5.25B | $5.28B | $5.00B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $3.59B | $3.13B | $2.80B | $2.47B | $2.36B |
| Cash & Equivalents | $1.34B | $1.08B | $0.80B | $0.76B | $0.58B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Sep '25 | FY24Sep '24 | FY23Sep '23 | FY22Sep '22 | FY21Sep '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.95B | $0.79B | $0.65B | $0.44B | $0.65B |
| Capital Expenditures | $0.04B | $0.03B | $0.05B | $0.03B | $0.03B |
| Free Cash Flow | $0.91B | $0.76B | $0.60B | $0.41B | $0.61B |
| Metric | FY25Sep '25 | FY24Sep '24 | FY23Sep '23 | FY22Sep '22 | FY21Sep '21 |
|---|---|---|---|---|---|
| Gross Margin | 81.4% | 80.2% | 78.9% | 80.0% | 81.1% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.1% | 0.2% |
| Net Margin | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 20.6% | 19.1% | 15.0% | 13.3% | 14.4% |
| Return on Assets | 11.6% | 10.4% | 7.5% | 6.3% | 6.8% |
| Debt / Equity | — | — | — | 0.14× | 0.16× |
